The neuroblastoma therapeutic market is estimated to be valued at USD 2.98 Bn in 2025 and is expected to reach USD 4.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. https://timessquarereporter.com/health/neuroblastoma-therapeutic-market-poised-for-growth-through-innovative-therapies